The company
Estrella Immunopharma, Inc.
ESLA · Nasdaq
ESLA stood above a rising 150-day average in 16 of the last 52 weekly readings, and has been out of that trend for the last 24 weeks. It is 55.3% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 24
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 15 (-1)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 16 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Jiandong XuChief Financial Officer | bought | 1,000at $1.33 | 7 Oct 2025filed 29 Apr 2026 |
| Jiandong XuChief Financial Officer | bought | 1,000at $1.16 | 22 Sep 2025filed 29 Apr 2026 |
| Jiandong XuChief Financial Officer | bought | 100at $1.04 | 11 Sep 2025filed 29 Apr 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| ARMISTICE CAPITAL, LLCreduced · filed 14 Aug 2026 | 3,975,220$4.1M | -123,780−3.0% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 416,852$434K | +34,383+9.0% |
| GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026 | 141,321$147K | -16,164−10.3% |
| VANGUARD FIDUCIARY TRUST COunchanged · filed 13 Aug 2026 | 64,921$68K | 00.0% |
| BlackRock, Inc.added · filed 7 Aug 2026 | 52,033$54K | +12,143+30.4% |
| STATE STREET CORPunchanged · filed 7 Aug 2026 | 43,252$45K | 00.0% |
| RENAISSANCE TECHNOLOGIES LLCreduced · filed 13 Aug 2026 | 39,100$41K | -23,695−37.7% |
| NORTHERN TRUST CORPadded · filed 13 Aug 2026 | 34,861$36K | +15,237+77.6% |
| US BANCORP \DE\added · filed 12 Aug 2026 | 20,000$21K | +3,096+18.3% |
| Tower Research Capital LLC (TRC)reduced · filed 11 Aug 2026 | 3,308$3,440 | -1,551−31.9% |
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.